# OnCo record fourlight-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/fourlight-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "fourlight-1", "NCT06105632" ;
  schema:name "FOURLIGHT-1"@en ;
  schema:description "In FOURLIGHT-1, a CDK4-only inhibitor designed to avoid the low blood counts of current CDK4/6 drugs improved progression-free survival in second line."@en ;
  schema:url <https://onco.cc/trials/fourlight-1/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06105632>, <https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-topline-phase-2-results-next> ;
  onco:status "positive" ;
  onco:phase "2" ;
  schema:startDate "2024-01-09" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:targets <https://onco.cc/targets/cdk4-6/> ;
  onco:drugs <https://onco.cc/drugs/atirmociclib/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .